The approved AD drugs by the FDA (donepezil, galantamine, tacrine, rivastigmine, and memantine) acting on acetylcholinesterase (AchE) or N-methyl-D-aspartate (NMDA) receptor can temporarily relieve the clinical symptoms but cannot reverse the disease progression [7]. The gene discussed is ACHE; the disease is Alzheimer disease.